Sign in

CIK 0001728328 · <br>Emerging growth company

InMed Pharmaceuticals Inc.

Sign in to watch
Tickers
INM MTRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(604) 669-7207
Business address
C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3

Securities

  • INM Common stock Nasdaq
  • MTRI Common Stock Nasdaq
  1. SCHEDULE 13D Stake Beneficial Ownership Report
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Material agreement · Acquisition or sale completed · Results of operations · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change
  18. 4 Open-market buy 10% owner bought 2,640 shares at $13.10 ($34,572)
  19. 8-K Event Regulation FD disclosure
  20. 8-K Event Regulation FD disclosure

Page 1 of 27 · 533 filings